Purpose: Leptin, an important hormone controlling energy homeostasis, has been linked to the pathogenesis of oral squamous cell carcinoma (OSCC). Evidence indicates that head and neck cancer patients undergoing radiotherapy show decreased leptin levels after radiotherapy treatment. Thus, we investigated, through phenotypic and molecular analyses, whether leptin can compromise the therapeutic effect of ionizing radiation and neoplastic behavior of OSCC cells.
Leptin is associated with development and progression of several cancer types, as breast, prostate, and lung, interfering on neoplastic phenotype, and expression of cancer-related genes. [4] [5] [6] The leptin treatment of human cancer cells led to the increase in cell proliferation, migration, and invasion; furthermore, it induced epithelial-tomesenchymal transition, indicating the more aggressive phenotype. 4 This hormone also enhanced neoplastic behavior and regulated the expression of cell cycle-related proteins, increasing cyclin D1 expression, and reducing the expression of p21 protein. 5 In oral carcinogenesis, the leptin signaling has aroused the interest of researchers due to possible involvement in disease pathogenesis. 7, 8 A study demonstrated through in vitro and in vivo assays that leptin increased the rates of cell proliferation and migration and reduced apoptosis. Accordingly, the leptin-treated oral squamous cell carcinoma (OSCC) cells showed high mRNA expression of genes related to the proliferation, migration, and angiogenesis. 9 Based on this knowledge, some studies investigated whether oncological treatment can change the leptin levels, showing conflicting results. 10, 11 For example, the surgery associated with adjuvant chemotherapy and radiotherapy did not modify levels of leptin, following treatment in breast cancer patients. 11 The leptin expression in gastro-oesophageal adenocarcinomas was related to the resistance to cytotoxic chemotherapy, showing increased expression in nonresponding patients to the therapy. 10 The head and neck cancer patients undergoing radiotherapy show decreased leptin levels by radiotherapy. 12 However, it is not well understood whether the increased leptin levels can interfere with the effect of cancer treatment in OSCC. Thus, through phenotypic and molecular assays, we tested the hypothesis that leptin can compromise the therapeutic effect of ionizing radiation and neoplastic behavior of OSCC cells. supplemented with 10% fetal bovine serum (Gibco, Invitrogen), antibiotics and 0.4 μg/mL hydrocortisone (Gibco, Invitrogen), and maintained at 37°C in a humidified atmosphere 5% CO 2 .
| MATERIALS AND METHODS

| Cell culture, leptin treatment, and irradiation
To in vitro assays, OSCC cells were treated with 100 ng/mL of recombinant human leptin (Invitrogen), for 72 hours, as described previously. 9 Next, the cells were irradiated at 6 Gy of single-dose cobalt-60 irradiation at a dose rate of 0.5 Gy/min, using a Telecobalt Machine Theratron Phoenix Philips SR 7510 (Eindhoven, Holanda). After 72 hours, the phenotype and molecular analyses were performed in triplicate and at least three independent times. 13 We adopted four experimental groups: control group, ionizing radiation alone (IR), leptin-treated group (Lep), and leptin plus irradiation group (Lep_IR).
| Cell proliferation assay
A density of 1 x 10 5 OSCC cells was plated in 6-well plates and submitted to the experimental treatments with leptin and radiation exposure. After treatments, cell counting was measured through trypan-blue exclusion.
| Migration assay
The OSCC cells were plated at a density of 8 was used to image analysis.
| Clonogenic assay
The OSCC cells were seeded in 6-well plates and exposure to the experimental treatments. After irradiation, the cells were kept at 37°C in a humidified incubator containing 5% CO 2 , for 72 hours.
Then, cells were trypsinized and plated again in 6-well plates at a density of 5 x 10 2 cells. It was maintained in growth medium for 10 days to forming colonies. Following this, colonies (cluster containing ≥50 cells) were fixed with 70% ethanol, stained with 2% Giemsa, and quantified by ImageJ software (NIH http://imagej.nih.gov/ij/).
The non-irradiated control was used for normalization of the surviving fraction of experimental groups.
| Reactive oxygen species assay
The OSCC cells were incubated with 10 μmol/L of 2′7′-dichlorofluor- Protein analysis was performed as the previously described method with appropriate modifications. 16 For data analysis, the spectra were acquired using software MassLynx v. 
| Statistical analysis
Statistical analysis was performed using SPSS 18.0 software and 3 | RESULTS
| Leptin reduced the suppressive effects of irradiation on the neoplastic phenotype of OSCC cells
To assess whether leptin interferes with ionizing radiation (IR) effect in OSCC cells, we performed the phenotypic assays of cell migration, death, and proliferation. Leptin was able to increase cell proliferation, despite the suppressive effect induced by radiation. Similar phenotypic behavior was observed in both OSCC cell lines ( Figure 1A and Figure S1A ). Furthermore, we identified that leptin reduced IRinduced cell death ( Figure 1B and Figure S1B ).
The radiation effect on cell migration was also reversed by leptin.
While the IR group showed lower migration percentage, the leptin treatment enhanced the migration ability of OSCC cells exposed to the radiation ( Figure 1C ).
| Leptin affected the sensitivity of OSCC cells to the ionizing radiation, reducing the colony-forming ability
To test the leptin effect on response/sensitivity of OSCC cells to radiation, we analyzed clonogenic formation. The cells treated with leptin showed low sensitivity to radiation, forming more cell clones than IR group ( Figure 1D ).
| Leptin inhibited radiation-induced ROS generation
The exposure of OSCC cells to IR led to the increased production of intracellular ROS. Instead, the leptin promoted the significant reduction of ROS accumulation in irradiated cells (Figure 2 ).
| Leptin increased expression of cancer-related proteins in irradiated OSCC cells
We carried out an MS-based proteomic analysis to identify whether leptin modifies proteins expression in OSCC cells exposed to the radiation. In total, 61 proteins were detected (Table S1 ), of which only three proteins were differentially expressed between groups, according to the fold change ratio >1.5. Leptin increased expression of ACTC1, KRT6A, and EEF2 proteins in irradiated cells (Figure 3) .
No protein showed significantly reduced expression between groups.
| DISCUSSION
The adjuvant radiotherapy to the surgery is an important treatment modality for advanced squamous cell carcinoma in head and neck region. However, an inadequate response to radiotherapy remains a fundamental barrier to prognosis. 17 So, the research of factors impairing the sensitivity of neoplastic cells to the ionizing radiation is hugely relevant to define therapeutic strategy better, to improve tumor remission and disease control. 18 The changes in the expression of proteins related to the cell cycle, apoptosis, and angiogenesis were shown to affect radiosensitivity of OSCC and HNSCC patients. 19, 20 For example, overexpression of Cyclin D1, EGFR and p53 was associated with resistance to chemoradiation, the risk of locoregional recurrence and metastasis in OSCC patients. 19 The leptin signaling pathway has emerged as an exciting target involved in development and progression of oral carcinogenesis 9 but
is not well knowledged whether increased levels of this hormone can to interfere with the effect of cancer treatment in OSCC. In this study, we found that leptin compromised the effect of ionizing radiation on the neoplastic behavior of OSCC cells. Despite the suppressive effect of irradiation, leptin enhances the proliferative phenotype and migration ability of OSCC cells exposed to the radiation. There is no precise knowledge about the molecular influence of leptin on cancer treatment, whether by radio-or chemotherapy. In a similar study to our own, it was demonstrated that leptin could stimulate myeloma proliferation, reducing the antitumor effect of chemotherapy by activating AKT and STAT3 pathways. 21 The therapeutic ionizing radiation acts on neoplastic cell inducing cell death by ROS generation. The radiation-induced high level of ROS promotes oxidative stress, and destabilization of cell integrity and metabolism of cancer cells, sensitizing them to undergo apoptosis. 22 Our results revealed that leptin decreased IR-induced cell death, accordingly with inhibition of ROS levels in irradiated cells. The leptin also led to the higher cell survival rates, evidenced by maintaining of cell multiplication and increase in the clonogenic formation after exposure to the radiation. A study identified that leptin could improve the bioenergetic efficiency of cancer cells, avoiding the ROS production and promoting the cell growth and survival. 23 Given the results found in this study, which the leptin impaired responsivity of OSCC cells to the ionizing radiation, we think to be reasonable to investigate whether leptin alters proteins expression in irradiated OSCC cells. Through MS-based proteomic analysis, we identified that the leptin promoted the increase of the expression of cancer-related proteins ACTC1, KRT6A, and EEF2.
The alpha cardiac muscle actin 1 (ACTC1), a cytoskeletal protein linked to cell motility, was associated with tumoral invasion. 24 The down-regulation of ACTC expression was identified in radiosensitive cells of HNSCC, after radiation treatment. 25 In our study, leptin treatment increased expression of ACTC and migration ability of OSCC cells exposed to the radiation.
The KRT6 or keratin 6A, type II member of the cytokeratin family, was shown as a potential biomarker to discriminate normal mucosa from OSCC. 26 However, its molecular role in pathways related to the therapeutic sensitivity was not investigated in oral cancer. We identified that leptin favored the KRT6A overexpression in irradiated neoplastic cells, while the control group showed lower expression levels.
The high activity of protein synthesis is one of the hallmarks of cancer cell metabolism. In this pathway, the eukaryotic translation elongation factor 2 (EEF2), an important factor for the polypeptide chain elongation step, is overexpressed in several cancer types and plays an oncogenic function in neoplastic cell growth. 27 The EEF2
overexpression was linked to progression of G2/M of the cell cycle, leading to the cancer cell growth. 28 Furthermore, its expression levels were significantly higher in colorectal, gastric cancer and HNSCC than healthy individuals. 27 Little is known about the influence of this protein on radiation sensitivity of cancer cells. Our results revealed the leptin favoring an increase in EEF2 expression in OSCC cells under therapeutic radiation, accordingly with higher cell proliferation rates.
Evidence indicates that EEF2 regulates activities of Akt, an import factor implicated in cell cycle progression. 28 Additionally, it was demonstrated that AKT is involved in response to radiation. 29 The activation of the PI3K/AKT/mTOR signaling pathway promoted radioresistance of OSCC. 30 So, this prompted us to think that leptin
The heat map is showing proteins analysis of differentially expressed proteins identified by mass spectrometry. The analysis considered the leptin-treated oral squamous cell carcinoma (OSCC) cells exposed to 6 Gy of ionizing irradiation (Leptin_IR group) and the control group of irradiated cells (Control_IR). Red Color indicates the proteins with the highest relevance score. Green indicates a lower score. The significantly upregulated proteins were defined according to the fold change ratio >1.5, and the P-value <0.05. Leptin increased expression of ACTC1, KRT6A, and EEF2 proteins in irradiated OSCC cells DA ROCHA ET AL.
can reduce the sensitivity of OSCC cells to radiation, increasing the cell proliferation, through upregulation of EEF2 protein.
Taken together, our findings point the leptin as an essential factor impairing the responsivity of OSCC cells to the ionizing radiation, reducing its suppressive effects on the neoplastic phenotype, and increasing protein expression of essential genes involved in carcinogenesis pathway. In this sense, we appointed a central question aiming to investigate whether obese individuals showing higher leptin levels would be less responsive to the radiotherapy to OSCC treatment. Thus, we highlight the need for more functional studies to better understanding the real importance of leptin in molecular events related to radiation effects in oral cancer.
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